Tests to help assess risk of acute kidney injury for people being considered for critical care admission (ARCHITECT and Alinity i Urine NGAL assays, BioPorto NGAL test and NephroCheck test)

Evidence-based recommendations on tests to help assess risk of acute kidney injury for people being considered for critical care admission. The tests are the ARCHITECT and ALINITY i Urine NGAL assays, BioPorto NGAL test and NephroCheck test.

Is this guidance up to date?

Next review: 2023

Guidance development process

How we develop NICE diagnostics guidance

This guidance replaces the NICE medtech innovation briefing on NephroCheck test to help assess the risk of acute kidney injury in critically ill patients (MIB156).